References
1. Najafi A, Chaechi Nosrati MR, Ghasemi E, Navi Z, Yousefi A, Majidiani H, et al. Is there association between Trichomonas vaginalis infection and prostate cancer risk?: A systematic review and meta-analysis. Microbial pathogenesis. 2019;137:103752.
2. Edwards T, Burke P, Smalley H, Hobbs G. Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis. Crit Rev Microbiol. 2016;42(3):406-17.
3. Krieger JN. Trichomoniasis in Men: Old Issues and New Data. Sexually Transmitted Diseases. 1995;22(2):83-96.
4. Kandamuthan S, Thambi R, Yeshodharan J. Trichomoniasis: Is it always sexually transmitted? Indian J Sex Transm Dis AIDS. 2014;35(2):166-7.
5. Mercer F, Johnson PJ. Trichomonas vaginalis: Pathogenesis, Symbiont Interactions, and Host Cell Immune Responses. Trends Parasitol. 2018;34(8):683-93.
6. Van Gerwen OT, Camino AF, Sharma J, Kissinger PJ, Muzny CA. Epidemiology, Natural History, Diagnosis, and Treatment of Trichomonas vaginalis in Men. Clin Infect Dis. 2021;73(6):1119-24.
7. Maeda S, Kubota Y, Senda Y, Tamaki M, Yasuda M, Deguchi T. Failure to detect urethral Trichomonas vaginalis in Japanese men with or without urethritis. Int J Urol. 2006;13(11):1418-20.
8. Kissinger PJ, Gaydos CA, Seña AC, Scott McClelland R, Soper D, Secor WE, et al. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis. 2022;74(Suppl_2):S152-s61.
9. Han IH, Kim JH, Ryu JS. Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia. Parasites Hosts Dis. 2023;61(1):2-14.
10. Momeni Z, Sadraei J, Kazemi B, Dalimi A. Trichomoniasis in older individuals: a preliminary report from Iran. J Parasit Dis. 2016;40(4):1597-600.
11. Lindrose AR, Htet KZ, O’Connell S, Marsh J, Kissinger PJ. Burden of trichomoniasis among older adults in the United States: a systematic review. Sex Health. 2022;19(3):151-6.